top of page

Leadership

Where no one has gone before

Executive Management

Andreas_Treml_headshot.png

Dr Andreas Treml,
Managing Director

Andreas Treml helms and oversees business operations, HR and manages budget and financial goals. As co-founder of Origenis he is contributing biological expertise to the management team.  In prior positions he was responsible for assay development and integrating ‘New Technologies’ for parallel biological characterization. Andreas holds a Ph.D. in biology and worked in the field of steroid hormone receptors and transcription factors for therapeutic oncology and across multiple therapeutic target areas during industrial and academic collaborations.

Senior Management

Michael-Almstetter.jpeg

Michael Almstetter, 
Chief Strategist

Cofounder of Origenis in 2005, leading the company through growth and private financing rounds, Michael created the basis for the later MOREsystem® with the invention of MolMind®. He also is responsible for the development of parallel chemistry, automated synthesis and analytics. He studied chemistry at the Technical University of Munich at the Organic Chemistry department of Prof. Dr. Ivar Ugi.

Roland_low.png

Dr Roland Köstler, Director Chemistry

Roland Köstler leads the chemistry team at Origenis. He is responsible for the design of novel compound classes, the development of their synthetic routes and involved in the IP protection. Additionally, he coordinates the external CMC activities. Roland holds a Ph.D. from the LMU Munich in Chemistry. He joined Origenis in 2008, and has more than 20 years’ experience in synthetic chemistry in many fields of medicinal chemistry, with the major focus on kinase inhibitors.

Nonexecutive Board

Hendrik Liebers,
Chairman of the Board

Hendrik has been active in the biotech industry for more than 25 years now. During that time he held positions as executive, board member and/ or shareholder of multiple companies, mainly in drug development, diagnostics, industrial biotechnology, agrobiotechnology and VC financing. During this time he was instrumental in more than 30 M&A- and Licensing transactions as well as capital raises with top tier funds. As an executive of Probiodrug AG he executed an IPO plus multiple follow on raises. Hendrik holds diplomas in molecular biology and economics, a doctor in medicine and a professorship in economics.

Hendrik Liebers.jpeg
Bernhard Strickler.jpg

Bernhard Strickler, Member of the Board

Bernhard has studied mechanical engineering and Physics.

Subsequently he was active for several years in low temperature research at Walther Meißner Institut and geophysical measurements in Iceland.

Afterwards he spent over 10 years in software development.

Nowadays he is mainly active as an investor in the field of biotechnology and mechanical engineering.

Werner Buser,
Member of the Board

Werner has been working for more than 30 years in various management position for Best Foods Int. in Europe. After his retirement as Senior Vice President and COO Supply Chain he acted as a “Business Angel” for Start-Ups in a broad range of sectors including software development, health care, flood protection systems, rapid hardening concrete, holiday resorts and biotechnology. He holds a diploma in economics and read “complexity management in supply chain”.

Werner Buser.jpg

Our Team

DSC_0159.jpeg
bottom of page